Richard Black

1 month ago | eir.news | Claudio Celani |Paul Gallagher |Carl Osgood |Richard Black

March 14, 2025 (EIRNS)—The EU “is like a sailboat at the mercy of the winds, with a crew of 27 hubs getting in each other’s way and no captain,” said Gustavo Piga, professor of political economy at the University of Rome Tor Vergata, in commenting on the ReArmEurope plan. In an interview with Il Sussidiario, Prof. Piga said that “von der Leyen is leading us toward disaster” as she is reacting to Trump without a strategy. This post is for paying subscribers only

1 month ago | eir.news | Claudio Celani |Paul Gallagher |Carl Osgood |Richard Black

March 14, 2025 (EIRNS)—The ReArmEurope plan is not a defense strategy, but a financial plan, said Gianandrea Gaiani, editor of the defense magazine Difesaonline. In a video interview with Giacomo Gabellini’s Blog Il Contesto, Gaiani said: “It is a financial program aimed at ensuring that there is a transfer of public and private funds, including those of savers, to investment funds, to systems that feed the defense industry.

1 month ago | eir.news | Paul Gallagher |Carl Osgood |Claudio Celani |Richard Black

March 14, 2025 (EIRNS)—Cryptocurrency issuers are (according to and to the crypto website Coindesk) expecting a White House Executive Order and legislation advancing in both Houses of Congress, to give them access to Federal Reserve payment systems, for example to be able to be used to purchase U.S. Treasury bills.

1 month ago | eir.news | Carl Osgood |Claudio Celani |Paul Gallagher |Richard Black

March 14, 2025 (EIRNS)—Europe’s arms makers are profiting hugely from the militarization of Europe. Yesterday, the New York Times ran a big story on Germany’s Rheinmetall which expects to profit handsomely from the militarization of Europe. “An era of rearmament has begun,” Armin Papperger, the chief executive of Rheinmetall, said Wednesday on an earnings call with analysts.

1 month ago | eir.news | Michael Billington |Richard Black |Cynthia R. Rush |Dennis Small

March 13, 2025 (EIRNS)—China’s National Medical Products Administration (NMPA) published a report on the role of fentanyl in the Chinese economy and exports, countering the U.S. claim that Beijing is pumping huge quantities of the killer drug into the U.S. through Mexico and Canada. Under the title “China Has Never Exported Fentanyl-Related Medications to North America: NMPA,” they report that fentanyl-related medications are primarily used for pain relief in clinical settings.